Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR mee
 

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 will be presented in a poster presentation at the American Association for Cancer Research Annual Meeting in Washington, DC.

More...